Skip to content

Author

Shu-Hong Luo

We have 6 of 20 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Proteomics in Antitumor Drug Target Discovery, Toxicity, Resistance, and Precision Oncology

Proteomics strategies are discussed, which enable the profiling of adverse drug reactions, the dissection of resistance mechanisms, and the advancement of precision oncology in antitumor drug development and precision oncology.

Qiang-Feng Zhong, Xiu-Li Wu, E. Wiechec et al. · 0 citations
Open access Sep 2026

Tumor specific cytokine pattern explored in renal cell carcinoma

Renal cell carcinoma (RCC) is a common urological malignancy, yet the cytokine landscape of the tumor microenvironment, especially in early-stage tumors, remains poorly defined. Using antibody arrays, 174 tumor-related cytokines were measured in 20 sets of normal, para-cancerous, and tumor tissues from early-stage RCC...

Xu Chen, Zhuang-Yao Liao, Rochelle Wickramasekara et al. · 0 citations
Aug 2026

Quantification of HPV-16 and HPV-18 Neutralizing Antibodies via a Magnetic Bead-Based Competitive Chemiluminescence Platform.

Persistent infection with high-risk human papillomavirus (HPV) types 16 and 18 is the primary cause of cervical cancer, and vaccination is an effective prevention method. The assessment of vaccine efficacy relies on measuring neutralizing antibodies (nAbs). However, the pseudovirion-based neutralization assay (PBNA), w...

Lin-Lin Wang, Wei-Ya Mao, Zhuo Zhang et al. · 0 citations
Open access Sep 2026

Assessing high-throughput surrogate assays for real-world HPV16- and HPV18-specific vaccine immune monitoring: a comparison of PBNA, cCLIA, and IgG

A stratified strategy for HPV16- and HPV18-specific immune monitoring using PBNA as a functional laboratory reference, cCLIA for high-throughput surrogate assessment, and IgG testing for population-level trend monitoring is supported.

Wei-Ya Mao, Meng Yuan, Zhao-Yang Fang et al. · 0 citations
Review Open access Sep 2026

Advances in protein microarray–based proteomics for gastric cancer applications in biomarker discovery, molecular subtyping, and precision oncology

The principles and major formats of protein microarray technologies and their applications in gastric cancer are summarized and current challenges and future directions for clinical translation are discussed.

Pan-Ning Wang, Yu-Lin Xiao, Shu-Hong Luo et al. · 0 citations
Review Open access Aug 2026

Proteomics of aging: biomarkers for physiological systems and diseases

This review synthesizes current evidence on proteomic biomarkers across major physiological systems, including the immune, metabolic/endocrine, cardiovascular, musculoskeletal, and nervous systems, and highlights shared molecular signatures that underpin multisystem decline.

Ying Luo, Yu-Lin Xiao, Jie-Hua Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.